BioCardia (BCDA) Current Assets (2010 - 2026)

BioCardia (BCDA) has reported Current Assets for 15 consecutive years, with $4.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets rose 258.47% year-over-year to $4.3 million in Q2 2026; TTM through Jun 2026 was $4.3 million, a 258.47% increase from a year earlier, with the FY2025 full-year figure at $2.7 million, up 4.2% from the prior year.
• Current Assets was $4.3 million for Q2 2026 at BioCardia, up from $1.1 million in the prior quarter.
• Over five years, Current Assets peaked at $10.7 million in Q1 2022 and troughed at $1.1 million in Q1 2026.
• A 5-year average of $4.2 million and a median of $3.5 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets slumped 81.42% in 2023 and soared 258.47% in 2026, its largest moves.
• Over 5 years, Current Assets stood at $7.9 million in 2022, then tumbled by 81.42% to $1.5 million in 2023, then jumped by 79.47% to $2.6 million in 2024, then advanced by 4.2% to $2.7 million in 2025, then soared by 57.32% to $4.3 million in 2026.
• The last three Current Assets figures came in at $4.3 million (Q2 2026), $1.1 million (Q1 2026), and $2.7 million (Q4 2025), per Business Quant data.